Tag Archives | SSASSA

A Breakthrough in Monitoring the Safety of ARVs and anti-TB Medicines in Swaziland

Adverse drug events among patients beginning new medicines can have disastrous consequences for treatment outcomes. The Swaziland Ministry of Health’s (MoH) National Pharmacovigilance Centre, the National Tuberculosis Control Programme, and the Swaziland National AIDS partnered with the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) to launch an […]

Read full story · Comments { 0 }